Substances With Anabolic And Other Hormonal Effect

Original Language Title: látky s anabolickým a jiným hormonálním účinkem

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now

Read the untranslated law here: https://portal.gov.cz/app/zakony/download?idBiblio=69930&nr=454~2F2009~20Sb.&ft=txt

454/2009 Sb.



GOVERNMENT REGULATION



of 7 November. December 2009,



amending, for the purposes of the Criminal Code provides for what is considered to be a substance

having an anabolic and other hormonal effect and what is their greater

quantity, and what, for the purposes of the Criminal Code considers the method

in terms of increasing the oxygen transfer in the human organism and for other

method with the dopingovým effect



Modified: 2/2012 Sb.



Government orders under section 289 paragraph. 4 of law No. 40/2009 Coll., the criminal

code:



§ 1



For substances with anabolic and other hormonal effect within the meaning of § 288

the Penal Code shall be regarded as substances which are listed in annex No. 1.

to this regulation.



§ 2



Larger amounts of the substances with anabolic and other hormonal effect

within the meaning of § 288 of the criminal code means more than one blister,

injection or similar usually indivisible medicine pack containing the following

substances or similar amounts of these substances in a special dopingovém

of the product.



§ 3



A method of increasing the oxygen transport in the body

and for the other methods with dopingovým effect within the meaning of section 288 of the criminal

code, consider the methods that are listed in annex 2 to this

of the regulation.



§ 4



This Regulation shall enter into force on 1 January 2000. January 1, 2010.



Prime Minister:



Ing. Fischer, CSc in r.



Minister of Justice:



JUDr. Kabelo in r.



Annex 1



Substances with anabolic and other hormonal effect



And.



ANABOLIC AGENTS



1. Anabolic Androgenic Steroids (AAS):



and) Exogenous AAS, including: 1-androstendiol

(5a-androst-1-en-3b, 17b-diol); 1-androstenedione

(5a-androst-1-Ene-3.17-Dione); bolandiol (19-norandrostendiol);

bolasteron; boldenone; boldion (androsta-1.4-diene-3.17-Dione);

calusteron; clostebol; danazol (17a-ethynyl-17b-hydroxyandrost-

4-eno [2,3-d] isoxazol); dehydrochlormetyltestosteron (4-chloro-

17B-hydroxy-17a-metylandrosta-1.4-dien-3-one); desoxymetyltestosteron

(17a-methyl-5a-androst-2-en-17b-ol); drostanolon; etylestrenol

(19-nor-17a-pregn-4-Ene-17-ol); fluoxymesterone; formebolon; furazabol

(17b-hydroxy-17a-methyl-5a-androstano [2,3-c]-furazan); gestrinon;

4-hydroxytestosteron (4, 17b-dihydroxyandrost-4-en-3-one); mestanolon;

mesterolone; metenolon; methandrostenolone

(17b-hydroxy-17a-metylandrosta-1.4-dien-3-one); metandriol; metasteron

(2a, 17a-dimethyl-5-androstane-3-one-17b-ol); metyldienolon

(17b-hydroxy-17a-metylestra-4.9-diene-3-one); methyl-1-testosterone

(17b-hydroxy-17a-methyl-5a-androst-1-en-3-one); metylnortestosteron

(17b-hydroxy-17a-metylestr-4-en-3-one); metyltrienolon

(17b-hydroxy-17a-4, metylestra-9,11-trien-3-one); metyltestosteron;

miboleron; nandrolone; 19-norandrostendion (estr-4-Ene-3.17-Dione);

norboleton; norclostebol; norethandrolone; oxabolon; oxandrolone;

oxymesteron; oxymetolon; prostanozol ([3,2-c] pyrazol-5-

etioallocholan-17b-tetrahydropyranol); quinbolon; stanozolol;

stenbolon; 1-testosterone (17b-hydroxy-5a-androst-1-en-3-one);

tetrahydrogestrinon (18a-homo-pregna-4, 9,11-trien-17b-ol-3-one);

trenbolone and other substances with a similar chemical structure or similar

biological effects.



b) Endogenous AAS:



Androstendiol (androst-5-en-3b, 17b-diol) androstenedione

(androst-4-Ene-3.17-Dione), prasteron (dehydroepiandrosterone DHEA),

dihydrotestosterone, testosterone, and the following metabolites and isomers:



5A-androstane-3a, 17a-diol



5A-androstane-3a, 17b-diol



5A-androstane-3b, 17a-diol



5A-androstane-3b, 17b-diol



androst-4-Ene-3a, 17a-diol



androst-4-Ene-3a, 17b-diol



androst-5-en-3b, 17a-diol



androst-5-en-3a, 17a-diol



androst-5-en-3a, 17b-diol



androst-5-en-3b, 17a-diol



4-androstendiol (androst-4-Ene-3b, 17b-diol)



5-androstenedione (androst-5-Ene-3.17-Dione)



EPI-dihydrotestosterone



3A-hydroxy-5aandrostan-17-on



3B-hydroxy-5aandrostan-17-on



19-norandrosteron



19-noretiocholanolon



and other substances with a similar chemical structure or similar

biological effects.



2.



Other anabolic agents, including:



Clenbuterol, selective androgenových receptor modulators (SARM),

tibolone, zeranol, zilpaterol and other substances having a similar effect.



(B).



HORMONES AND RELATED SUBSTANCES



1. substances erythropoeisis stimulating (e.g. erythropoietin EPO, darbepoetin

Depot);



2. Growth hormone (hGH), insulin like growth factors (e.g..

IGF-1), mechanical growth factor (MGF);



3. the gonadotropins (hCG); and the luteinizing hormone (LH)



4. Insulin;



5. Kortikotropiny;



and other substances with a similar chemical structure or similar

biological effects and their releasing factors.



(C).



HORMONE ANTAGONISTS AND MODULATORS



1. Inhibitors of aromatáz, including:



Aminoglutethimid, anastrozole, exemestane, letrozole, formestan,

testolacton, but not limited to them.



2. selective estrogen receptor modulators (SERMS), including:



Raloxifene, tamoxifen, Toremifene, but not limited to them.



3. other estrogenic substances including:



Cyklofenil, fulvestrant, clomiphene



4. substances modifying myostatin functions including myostatin inhibitors.



Annex 2



Method with the dopingovým effect



And.



INCREASING THE OXYGEN TRANSFER



1. Blood doping, including the use of autologous, homologous or heterologous

blood or red blood cells, and similar products, of any

origin.



2. Artificial increasing consumption, transport or delivery of oxygen, involving

genetically modified hemoglobinové products (e.g. blood substitutes based on the

hemoglobin, haemoglobin mikroenkapsulované), perfluorochemicals and

efaproxiral (RSR13) and other products with a similar effect.



(B).



GENE DOPING



1. Transfer of nucleic acids or their sequences with potential

to enhance athletic performance.



2. the use of normal or genetically modified cells with the potential to

to enhance athletic performance.



3. the use of substances that directly or indirectly affect the function known for its

the influence on the performance by modifying gene expression, such as receptor

Delta peroxizomovými proliferátory/Peroxisome activated By

The activated Receptor d (PPARd) agonists/(e.g. GW 1516) and Agonists

axis proteinkinasové AMP-activated in conjunction with the PPAR delta

/PPARdelta-AMP-activated protein kinase (AMPK) axis agonists/

(e.g. AICAR).